Table 2.
Univariate and multivariate analyses of overall survival.
| Cancer type | Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | |||
| GBM/LGG | WHO grade (G3&G4 vs. G2) | 634 | 5.642 (3.926-8.109) | <0.001 | 2.411 (1.556-3.735) | <0.001 |
| KIRC | T stage (T2&T3&T4 vs. T1) | 539 | 2.917 (2.095-4.061) | <0.001 | 1.340 (0.811-2.212) | 0.253 |
| N stage (N1 vs. N0) | 257 | 3.453 (1.832-6.508) | <0.001 | 1.788 (0.927-3.450) | 0.083 | |
| M stage (M1 vs. M0) | 506 | 4.389 (3.212-5.999) | <0.001 | 3.403 (2.108-5.496) | <0.001 | |
| KIRP | Pathologic T stage (T2&T3&T4 vs. T1) | 286 | 5.074 (2.637-9.765) | <0.001 | 0.828 (0.165-4.161) | 0.819 |
| Pathologic N stage (N1&N2 vs. N0) | 77 | 5.003 (2.062-12.140) | <0.001 | 1.819 (0.396-8.350) | 0.442 | |
| Pathologic M stage (M1 vs. M0) | 104 | 114.966 (22.481-587.925) | <0.001 | 51.689 (4.901-545.151) | 0.001 | |
| STAD | T stage (T3&T4 vs. T1&T2) | 362 | 1.719 (1.131-2.612) | 0.011 | 1.450 (0.919-2.290) | 0.111 |
| N stage (N1&N2&N3 vs. N0) | 352 | 1.925 (1.264-2.931) | 0.002 | 1.661 (1.058-2.607) | 0.028 | |
| M stage (M1 vs. M0) | 352 | 2.254 (1.295-3.924) | 0.004 | 1.866 (1.057-3.293) | 0.031 | |
The meaning of the bold values was regarded as statistically significant.